Two Sigma Investments
VAXX

Two Sigma Investments’s Vaxxinity, Inc. Class A Common Stock VAXX Stock Holding History

Two Sigma Investments’s Portfolio VAXX Stock Details VAXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-17,796
Closed -$40.4K – 3358
2023
Q1 		$40.4K Buy
+17,796
New +$45.1K ﹤0.01% 2784
2022
Q4 		– Sell
-24,947
Closed -$49K – 3147
2022
Q3 		$49K Sell
24,947
-103,569
-81% -$216K ﹤0.01% 2318
2022
Q2 		$202K Buy
+128,516
New +$486K ﹤0.01% 2163

Other funds holding VAXX

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
PFO
Pathstone Family Office Englewood, New Jersey $13.1B AUM 21.02% 1-Year Est. Return
SM
Scoggin Management New York $1.04B AUM 232.32% 1-Year Est. Return

Two Sigma Investments's VAXX Position: Q2 2023 in Review

Two Sigma Investments sold out of Vaxxinity, Inc. Class A Common Stock (VAXX) in Q2 2023, closing a stake of 17,796 shares — an estimated $40.4K sold.

Two Sigma Investments first reported a position in VAXX in Q2 2022 and held it in 3 quarters. The position peaked at $202K in Q2 2022. 49 funds tracked by Wall St. Rank hold VAXX as of Q2 2023.

  • Two Sigma Investments reported no remaining Vaxxinity, Inc. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
  • Two Sigma Investments sold 17,796 Vaxxinity, Inc. Class A Common Stock shares in Q2 2023, an estimated $40.4K.
  • Two Sigma Investments first reported a position in Vaxxinity, Inc. Class A Common Stock in Q2 2022 and held it in 3 quarters.
  • Two Sigma Investments's Vaxxinity, Inc. Class A Common Stock position peaked at $202K in Q2 2022.
  • 49 funds tracked by Wall St. Rank held Vaxxinity, Inc. Class A Common Stock as of Q2 2023.

Based on Two Sigma Investments's 13F filing for Q2 2023, filed 14 Aug 2023.